396 related articles for article (PubMed ID: 24164374)
41. Impact of molecular testing in the diagnosis of thyroid fine needle aspiration cytology: data from mainland China.
Guo HQ; Zhao H; Zhang ZH; Zhu YL; Xiao T; Pan QJ
Dis Markers; 2014; 2014():912182. PubMed ID: 24591770
[TBL] [Abstract][Full Text] [Related]
42. A clinical algorithm for fine-needle aspiration molecular testing effectively guides the appropriate extent of initial thyroidectomy.
Yip L; Wharry LI; Armstrong MJ; Silbermann A; McCoy KL; Stang MT; Ohori NP; LeBeau SO; Coyne C; Nikiforova MN; Bauman JE; Johnson JT; Tublin ME; Hodak SP; Nikiforov YE; Carty SE
Ann Surg; 2014 Jul; 260(1):163-8. PubMed ID: 24901361
[TBL] [Abstract][Full Text] [Related]
43. Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules.
Cohen Y; Rosenbaum E; Clark DP; Zeiger MA; Umbricht CB; Tufano RP; Sidransky D; Westra WH
Clin Cancer Res; 2004 Apr; 10(8):2761-5. PubMed ID: 15102681
[TBL] [Abstract][Full Text] [Related]
44. Clinical management of thyroid nodules with indeterminate cytology: our institutional experience using SIAPEC cytological criteria and V600-BRAF test.
Di Benedetto G; Fabozzi A; Rinaldi C
Pathologica; 2013 Feb; 105(1):1-4. PubMed ID: 23858942
[TBL] [Abstract][Full Text] [Related]
45. Role of BRAF molecular analysis in the management of papillary thyroid carcinoma: analysis of cytological and histological samples.
Capelli L; Marfisi C; Puccetti M; Saragoni L; De Paola F; Zaccaroni A; Chiadini E; Gagliardi L; Ferretti G; Zoli W; Ulivi P
Cytopathology; 2015 Oct; 26(5):297-302. PubMed ID: 25123949
[TBL] [Abstract][Full Text] [Related]
46. Fine needle aspiration cytology in diagnosis and management of thyroid disease.
Bajaj Y; De M; Thompson A
J Laryngol Otol; 2006 Jun; 120(6):467-9. PubMed ID: 16526971
[TBL] [Abstract][Full Text] [Related]
47. Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules.
Eszlinger M; Krogdahl A; Münz S; Rehfeld C; Precht Jensen EM; Ferraz C; Bösenberg E; Drieschner N; Scholz M; Hegedüs L; Paschke R
Thyroid; 2014 Feb; 24(2):305-13. PubMed ID: 23837487
[TBL] [Abstract][Full Text] [Related]
48. A large series of hyalinizing trabecular tumors: Cytomorphology and ancillary techniques on fine needle aspiration.
Dell'Aquila M; Gravina C; Cocomazzi A; Capodimonti S; Musarra T; Sfregola S; Fiorentino V; Revelli L; Martini M; Fadda G; Pantanowitz L; Larocca LM; Rossi ED
Cancer Cytopathol; 2019 Jun; 127(6):390-398. PubMed ID: 31135104
[TBL] [Abstract][Full Text] [Related]
49. [Diagnostic value of BRAFV600E and RET/PTC oncogenes in thyroid nodule aspirates].
Guerra A; Carrano M; Angrisani E; Vitale M
Recenti Prog Med; 2013; 104(7-8):415-9. PubMed ID: 24042420
[TBL] [Abstract][Full Text] [Related]
50. BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid.
Jin L; Sebo TJ; Nakamura N; Qian X; Oliveira A; Majerus JA; Johnson MR; Lloyd RV
Diagn Mol Pathol; 2006 Sep; 15(3):136-43. PubMed ID: 16932068
[TBL] [Abstract][Full Text] [Related]
51. Incidence and predictive factors of inadequate fine-needle aspirates for BRAF(V600E) mutation analysis in thyroid nodules.
Lee KH; Kim HS; Han BK; Ko EY; Ki CS; Shin JH
AJR Am J Roentgenol; 2014 Feb; 202(2):391-6. PubMed ID: 24450682
[TBL] [Abstract][Full Text] [Related]
52. An effective approach for BRAF V600E mutation analysis of routine thyroid fine needle aspirates.
Agrawal T; Xi L; Navarro W; Raffeld M; Patel SB; Roth MJ; Klubo-Gwiezdzinska J; Filie AC
Cytopathology; 2022 May; 33(3):344-349. PubMed ID: 34957617
[TBL] [Abstract][Full Text] [Related]
53. Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience.
Bongiovanni M; Molinari F; Eszlinger M; Paschke R; Barizzi J; Merlo E; Giovanella L; Fasolini F; Cattaneo F; Ramelli F; Mazzucchelli L; Frattini M
Cytopathology; 2015 Oct; 26(5):288-96. PubMed ID: 25487739
[TBL] [Abstract][Full Text] [Related]
54. Role of BRAFV600E mutation analysis and second cytologic review of fine-needle aspiration for evaluating thyroid nodule.
Kang G; Cho EY; Shin JH; Chung JH; Kim JW; Oh YL
Cancer Cytopathol; 2012 Feb; 120(1):44-51. PubMed ID: 21751431
[TBL] [Abstract][Full Text] [Related]
55. Fine-needle Aspiration Washout Precipitation Specimens: An Acceptable Supplement to Genetic Mutation Detection of Thyroid Nodules.
Cui Y; Huang X; Guo J; Zhang N; Liang J; Zhang Y; Liao Y; He D
Technol Cancer Res Treat; 2021; 20():15330338211057982. PubMed ID: 34806478
[No Abstract] [Full Text] [Related]
56. Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status.
Kim SK; Hwang TS; Yoo YB; Han HS; Kim DL; Song KH; Lim SD; Kim WS; Paik NS
J Clin Endocrinol Metab; 2011 Mar; 96(3):658-64. PubMed ID: 21239517
[TBL] [Abstract][Full Text] [Related]
57. High BRAFV600E mutation frequency in Chinese patients with papillary thyroid carcinoma increases diagnostic efficacy in cytologically indeterminate thyroid nodules.
Li XJ; Mao XD; Chen GF; Wang QF; Chu XQ; Hu X; Ding WB; Zeng Z; Wang JH; Xu SH; Liu C
Medicine (Baltimore); 2019 Jul; 98(28):e16343. PubMed ID: 31305422
[TBL] [Abstract][Full Text] [Related]
58. BRAF V600E as an accurate marker to complement fine needle aspiration (FNA) cytology in the guidance of thyroid surgery in the Chinese population: evidence from over 1000 consecutive FNAs with follow-up.
Zhao Q; Wang Y; Ye Q; Wang P; Rao J
Jpn J Clin Oncol; 2021 Apr; 51(4):590-594. PubMed ID: 33237284
[TBL] [Abstract][Full Text] [Related]
59. The molecular diagnosis and management of thyroid neoplasms.
Theoharis C; Roman S; Sosa JA
Curr Opin Oncol; 2012 Jan; 24(1):35-41. PubMed ID: 22123232
[TBL] [Abstract][Full Text] [Related]
60. VE1 antibody is not highly specific for the BRAF V600E mutation in thyroid cytology categories with the exception of malignant cases.
Lee SR; Yim H; Han JH; Lee KB; Lee J; Soh EY; Kim DJ; Chung YS; Jeong SY; Sheen SS; Park SH; Kim JH
Am J Clin Pathol; 2015 Mar; 143(3):437-44. PubMed ID: 25696803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
